Diseases [C] » Nervous System Diseases [C10] » Neurotoxicity Syndromes
Diseases [C] » Chemically-Induced Disorders [C25] » Poisoning » Neurotoxicity Syndromes
Description
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. MeSH
Hierarchy View
Subtype Terms (7)
Akathisia, Drug-Induced
3 drugs (2 approved, 1 experimental)
Alcohol-Induced Disorders, Nervous System
1 approved drug
Botulism
9 drugs (5 approved, 4 experimental)
Dyskinesia, Drug-Induced
13 drugs (8 approved, 5 experimental)
Phase 3 Indicated Drugs (5)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (45)
Bangabandhu Sheikh Mujib Medical University
BioNumerik Pharmaceuticals, Inc.
Cancer and Leukemia Group B (CALGB)
National Cancer Institute (NCI)
North Central Cancer Treatment Group
Oregon Health and Science University
Organization Involved with Phase 2 Indications (31)
ECOG-ACRIN Cancer Research Group
Herbert Irving Comprehensive Cancer Center
Hospital Universitario de Fuenlabrada
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.